ImmuCell Stock Price. Everything You Need To Know About The ImmuCell Stock!
ImmuCell Corp. is a company based in Portland, Maine that is focused on the development, acquisition, manufacture, and sale of products for improving the health and productivity of dairy and beef cattle. With 67 full-time employees, the firm offers a range of products that aim to prevent scours in newborn dairy and beef calves, such as its First Defense product line.
The company has expanded its First Defense product line into five different products, with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus, and rotavirus pathogens. Its Tri-Shield First Defense product line extension is a calf-level, passive antibody product that provides immediate immunity against E. coli, coronavirus, and rotavirus.
ImmuCell Corp. is also engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The company’s products are designed to reduce the use of traditional antibiotics in food-producing animals.
As with any investment opportunity, it is important to conduct thorough research and analysis before investing in a stock. Keeping up to date with the latest developments in the industry and the company’s performance can help investors make informed decisions. For example, staying informed about the stock price today, premarket trends, and stocks share price today can help investors understand the company’s market position and make more informed investment decisions. However, it is important to remember that investing in the stock market carries risks and it is essential to make investment decisions based on your personal financial situation and investment goals.
ImmuCell Stock Price. Everything You Need To Know About The ImmuCell Stock! performance
- Employees 67
- Company HQ Portland
- Website http://www.immucell.com/
- ICCC Asset Type Common Stock
- ICCC Market Capitalization 39.8M
- Earnings Per Share -0.75
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.634
ImmuCell is a cutting-edge biotechnology company that develops and manufactures innovative products for the dairy and beef industries. With a strong focus on animal health and wellness, ImmuCell’s revolutionary solutions enhance the productivity and profitability of livestock producers, making it an attractive investment opportunity. But how can retail investors from Malaysia, Thailand, Indonesia, and Vietnam tap into this potentially lucrative stock? Zorion, the leading investment platform, provides a seamless solution. Through Zorion’s user-friendly interface and expert investment advice, retail investors can confidently invest in ImmuCell. Access insightful recommendations and educational resources to gain comprehensive knowledge and make informed decisions about your investment journey. Explore the vast potential of ImmuCell and start your investment through Zorion today.
